A Case of Pulmonary Alveolar Proteinosis Improved with Inhaled Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) / 대한내과학회지
Korean Journal of Medicine
; : 357-361, 2012.
Article
in Ko
| WPRIM
| ID: wpr-148199
Responsible library:
WPRO
ABSTRACT
Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of lipoproteinaceous material within the alveoli. Several studies have recently found that autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) play a major role in the pathogenesis of idiopathic PAP. Consequently, inhaled or systemic injection of GM-CSF has been suggested as a promising treatment for PAP. A 54-year-old male visited our hospital for progressive dyspnea. Four years earlier, he was diagnosed with PAP based on a surgical lung biopsy in another institution. Whole-lung lavage was performed four times before he visited our hospital. We administered high-dose inhaled GM-CSF therapy for 12 weeks followed by 12 weeks of low-dose therapy. After the GM-CSF treatment, the patient's symptoms, lung function, and radiological findings were improved significantly.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Pulmonary Alveolar Proteinosis
/
Autoantibodies
/
Biopsy
/
Administration, Inhalation
/
Granulocyte-Macrophage Colony-Stimulating Factor
/
Dyspnea
/
Therapeutic Irrigation
/
Lung
/
Lung Diseases
Limits:
Humans
/
Male
Language:
Ko
Journal:
Korean Journal of Medicine
Year:
2012
Type:
Article